Blackstone to make $500m pharma investment(2)

Set to bolster its pharmaceuticals portfolio, Blackstone has agreed to make a $500 million minority investment in Florida-based Stiefel Laboratories.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this